ErgoMed, Inc

Form 483 issued October 5, 2022 · San Antonio, Texas

Inspection
Oct 3 – Oct 5, 2022
Investigator
Christine I. Shaw
Observations
6
Pages
5
FEI number
1000306115

In short: On October 5, 2022, FDA issued a Form 483 with 6 observations to ErgoMed, Inc in San Antonio, Texas (FEI 1000306115) after an inspection that ran Oct 3 – Oct 5, 2022. The investigator was Christine I. Shaw. Most observations concern production & process controls and cAPA.

At a glance

Production & process controls and capa account for 4 of 6 observations.

Production & process controls2
CAPA2
Management controls1
Records & documents1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures to ensure that all purchased or otherwise received product and services conform to specified requirements…

  2. 02

    Procedures for acceptance activities have…

  3. 03

    Procedures have not been established to control product that does not…

  4. 04

    The written MDR Procedme does not include an internal system which provides for timely and effective…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at ErgoMed, Inc?

FDA listed 6 observations on this Form 483, mostly about production & process controls, cAPA and management controls. The opening words of each observation are shown on this page.

Who inspected ErgoMed, Inc?

Christine I. Shaw is named on this Form 483, for the inspection of Oct 3 – Oct 5, 2022. Each investigator has a profile showing what they cite most.

When was ErgoMed, Inc inspected by FDA?

The inspection ran Oct 3 – Oct 5, 2022, and the Form 483 is dated October 5, 2022.

How do I get the full Form 483 for ErgoMed, Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free